These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms]. Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886 [TBL] [Abstract][Full Text] [Related]
3. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms]. Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495 [TBL] [Abstract][Full Text] [Related]
4. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung]. Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610 [TBL] [Abstract][Full Text] [Related]
5. [Auxiliary value of TPA in diagnosing neoplastic diseases]. Mizushima Y; Nakamura F; Yokoyama A; Morikage T; Kawasaki S; Hoshino K; Maruyama M; Yamashita N; Yano S Gan No Rinsho; 1986 Jun; 32(7):779-82. PubMed ID: 3735675 [TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of CEA levels in lung cancer]. Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691 [TBL] [Abstract][Full Text] [Related]
7. [The sensitivity and specificity of tumor markers (CEA, ferritin, beta 2-MG, TPA, IAP, sialic acid) in malignant and non-malignant pulmonary diseases and their relation to smoking and sex]. Reshad K; Suzuki K; Inui K; Takahashi Y; Umemiya M; Nakano Y; Sakamoto M; Takeuchi Y; Shimada T Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1343-50. PubMed ID: 3912573 [No Abstract] [Full Text] [Related]
8. CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group. Kulpa J; Wójcik E; Radkowski A; Kolodziejski L; Stasik Z Anticancer Res; 2000; 20(6D):5035-40. PubMed ID: 11326663 [TBL] [Abstract][Full Text] [Related]
9. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels. Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851 [TBL] [Abstract][Full Text] [Related]
10. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma. Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827 [TBL] [Abstract][Full Text] [Related]
11. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract]. Tappero G; Piantino P; Cerchier A; Pecchio F Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313 [TBL] [Abstract][Full Text] [Related]
12. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA]. Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670 [TBL] [Abstract][Full Text] [Related]
13. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]. Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of tumor markers in breast cancer patients]. Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907 [TBL] [Abstract][Full Text] [Related]
15. [The diagnostic values of CA242 combining other tumor markers for lung cancer]. Zhang S; Ma Y; Yang X Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851 [TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study. Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259 [TBL] [Abstract][Full Text] [Related]
17. [Tumor marker in lung cancer]. Shijubo N; Abe S Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790 [No Abstract] [Full Text] [Related]
18. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093 [TBL] [Abstract][Full Text] [Related]
19. [Distribution and prognostic value of CEA and TPA in cancer of the lung]. Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330 [TBL] [Abstract][Full Text] [Related]
20. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage]. Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]